COMMUNIQUÉS West-GlobeNewswire

TESARO Announces Achievement of ZEJULA Prostate Cancer Development Milestones by Janssen
29/10/2018
WALTHAM, Mass., Oct. 29, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced the achievement of development milestones that trigger an $18 million payment [...]
Protech Home Medical Announces Insider Subscriptions
29/10/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CINCINNATI, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (“ PHM ” or the “ Company ”) (TSXV: PHM), is [...]
Iovance Biotherapeutics to Host Melanoma Program Update Event for Analysts and Investors During SITC 2018
29/10/2018
SAN CARLOS, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology [...]
Loop Industries Endorses the New Plastics Economy Global Commitment – Helping Keep Plastic in the Economy and Out of Nature
29/10/2018
MONTREAL, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq: LOOP), a leading technology innovator in sustainable plastic, today announced that it has joined leading global consumer brands, including [...]
HempAmericana Retires All Outstanding Convertible Debt
29/10/2018
NEW YORK, Oct. 29, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is proud to announce the retirement of all outstanding convertible debt. As of the filing [...]
BrainStorm Announces Financial Results for the Third Quarter of 2018 and Provides a Corporate Update
29/10/2018
Highlights Scientific Advances and Continued Progress for NurOwn ® in ALS Towards U.S. FDA Approval; Following Successful FDA Pre-IND Meeting, BrainStorm will File an IND for NurOwn ® in a Second Clinical Indication [...]
XBiotech annonce de nouveaux brevets au troisième trimestre 2018
29/10/2018
Demande/ autorisation de brevets pour des traitements candidats de la Société destinés aux maladies cardiovasculaires, aux infections par staphylocoque doré et à sa technologie de découverte d’antibiotiques AUSTIN ( [...]
ProQR In-licenses Worldwide Rights to Ophthalmology Drug Candidate from Ionis Pharmaceuticals
29/10/2018
ProQR receives exclusive worldwide license for IONIS-RHO-2.5 Rx , now QR-1123, for autosomal dominant retinitis pigmentosa (adRP), a rare inherited form of blindness with no approved therapy A first in human Phase 1/2 [...]
United States Department of Health and Human Services Publishes New HIV Treatment Guidelines Including Trogarzo®
29/10/2018
MONTREAL, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Trogarzo ® (ibalizumab-uiyk) injection is now included in the most recent version of the [...]
Le United States Department of Health and Human Services publie des directives de traitement du VIH incluant Trogarzo(MD)
29/10/2018
MONTRÉAL, 29 oct. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que Trogarzo MD (ibalizumab-uiyk) injection fait maintenant partie des plus récentes directives de [...]
Kura Oncology to Report Third Quarter 2018 Financial Results
29/10/2018
SAN DIEGO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will [...]
VIVUS Adds Two New Members to the Board of Directors
29/10/2018
Karen Ferrell and Edward A. Kangas Expand VIVUS’ Board to Nine Members CAMPBELL, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, today announced that [...]
Otonomy to Report Third Quarter 2018 Financial Results and Provide Corporate Update
29/10/2018
Webcast and Conference Call to be Held at 4:30 p.m. EST on November 5, 2018 SAN DIEGO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of [...]
Marinus Pharmaceuticals Provides Business Update and Third Quarter 2018 Financial Results
29/10/2018
RADNOR, Pa., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (“Marinus” or “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy [...]
Radient Technologies Inc. Files Provisional Applications for Innovating Cannabis Extraction and Announces Graduation to Tier 1 Issuer Status on the TSX Venture Exchange
29/10/2018
EDMONTON, Alberta, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI ) is pleased to announce that it has filed 18 provisional patent applications with the U.S. [...]
Canada House Wellness Group Provides Update on Production Facility
29/10/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES PICKERING, Ontario, Oct. 29, 2018 (GLOBE NEWSWIRE) -- As product shortages characterized the first week of legal cannabis sales across [...]
Aleafia to Launch Cannabis R&D Division Aleafia Labs
29/10/2018
Patient Data, Intellectual Property to be Used in Development of Proprietary Products TORONTO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. ( TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH ) (“ Aleafia “) or (the “Company [...]
Akorn Receives Product Approval
29/10/2018
LAKE FOREST, Ill., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that, on October 26, 2018, it received a new Abbreviated New Drug [...]
Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials
29/10/2018
BUFFALO, N.Y., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Pages